Global X Management Company’s Vertex Pharmaceuticals VRTX Stock Holding History

Global X Management Company’s Portfolio VRTX Stock Details VRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	$999K	Sell	5,876 -1,181	-17%	-$183K	0.02%	471
2018 Q1	$1.15M	Buy	7,057 +1,271	+22%	+$208K	0.02%	381
2017 Q4	$867K	Buy	5,786 +787	+16%	+$117K	0.02%	404
2017 Q3	$760K	Buy	4,999 +558	+13%	+$84K	0.02%	426
2017 Q2	$572K	Buy	4,441 +1,693	+62%	+$204K	0.02%	476
2017 Q1	$300K	Buy	2,748 +535	+24%	+$47.1K	0.01%	618
2016 Q4	$163K	Buy	2,213 +656	+42%	+$53.4K	0.01%	718
2016 Q3	$136K	Buy	1,557 +955	+159%	+$90.3K	0.01%	682
2016 Q2	$52K	Buy	602 +424	+238%	+$36.6K	﹤0.01%	697
2016 Q1	$14K	Buy	178 +160	+889%	+$14.5K	﹤0.01%	838
2015 Q4	$2K	Hold	18	–	–	﹤0.01%	817
2015 Q3	$2K	Hold	18	–	–	﹤0.01%	918
2015 Q2	$2K	Buy	+18	New	+$2.27K	﹤0.01%	888

Other funds holding VRTX

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

Global X Management Company's VRTX Position: Q2 2018 in Review

Global X Management Company reduced its Vertex Pharmaceuticals (VRTX) stake by 17% in Q2 2018, selling an estimated $183K and leaving 5,876 shares worth $999K. The position accounts for 0.02% of the portfolio, ranked #471.

Global X Management Company first reported a position in VRTX in Q2 2015 and has held it in 13 quarters since. The position peaked at $1.15M in Q1 2018. 690 funds tracked by Wall St. Rank hold VRTX as of Q2 2018.

Global X Management Company held 5,876 shares of Vertex Pharmaceuticals worth $999K as of Q2 2018.
Global X Management Company sold 1,181 Vertex Pharmaceuticals shares in Q2 2018, an estimated $183K.
Vertex Pharmaceuticals made up 0.02% of Global X Management Company's portfolio in Q2 2018, its #471 holding.
Global X Management Company first reported a position in Vertex Pharmaceuticals in Q2 2015 and has held it in 13 quarters since.
Global X Management Company's Vertex Pharmaceuticals position peaked at $1.15M in Q1 2018.
690 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2018.

Based on Global X Management Company's 13F filing for Q2 2018, filed 16 Aug 2018.